EMEA-001136-PIP02-19-M01
Key facts
| Invented name |
Doptelet
|
| Active substance |
Avatrombopag
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0482/2020
|
| PIP number |
EMEA-001136-PIP02-19-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of chemotherapy-induced thrombocytopenia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Dova Pharmaceuticals Ireland Limited
E-mail: medical.info@sobi.com
Tel: +46 86972000 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|